Tag Archive for: Perseris

The drugmaker slashed its 2024 profit forecast while signaling a slowdown in sales of its top-selling opioid addiction treatment, and said it would discontinue sales of its schizophrenia drug Perseris, prompting its shares to plunge 44% on Tuesday.

The global pharmaceutical company has tapped McKinney to lead strategy, creative and digital for Sublocade and Perseris